Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

Jeffrey C Hageman1, Timothy M Uyeki, John S Francis

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. JHageman@cdc.gov

Insights

Severe community-acquired pneumonia (CAP) during flu season is often linked to methicillin-resistant Staphylococcus aureus (MRSA). Early consideration of MRSA in treatment is crucial, especially in high-prevalence areas.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) poses a significant health burden.
  • Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), is an emerging cause of severe CAP.
  • Influenza virus coinfection is increasingly recognized in severe bacterial pneumonia.

Purpose of the Study:

  • To investigate the characteristics and outcomes of Staphylococcus aureus CAP cases during the 2003-04 influenza season.
  • To identify risk factors and microbiological features associated with MRSA in severe CAP.
  • To inform clinical management strategies for severe CAP during influenza outbreaks.

Main Methods:

  • Retrospective analysis of 17 S. aureus CAP cases reported across 9 states during the 2003-04 influenza season.
  • Clinical data collection including patient demographics, underlying conditions, risk factors, and outcomes.
  • Microbiological characterization of S. aureus isolates, including antibiotic susceptibility, toxin gene profiling (Panton-Valentine leukocidin), and molecular typing (PFGE, SCCmec).
  • Laboratory confirmation of influenza virus infection.

Main Results:

  • 17 S. aureus CAP cases were identified; 15 (88%) were MRSA.
  • The median patient age was 21 years, with 29% having underlying diseases and 24% having MRSA risk factors.
  • Influenza virus infection was present in 71% of patients.
  • The overall mortality rate was 29% (5 deaths), with 4 deaths attributed to MRSA.
  • All S. aureus isolates carried toxin genes, predominantly Panton-Valentine leukocidin (85%).
  • MRSA isolates exhibited community-associated PFGE patterns and SCCmec type IVa.

Conclusions:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of severe community-acquired pneumonia (CAP), especially when associated with influenza virus infection.
  • The genotypic and phenotypic characteristics of these MRSA isolates are consistent with community-acquired strains.
  • Empiric antibiotic therapy for severe CAP during influenza seasons in areas with high MRSA prevalence should include coverage for MRSA.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: